Abstract
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) can cause a hypercoagulable state leading to coronary artery thrombosis. The optimal management of this phenomenon has not been well elucidated. We describe a 38-year-old male who developed an ST-elevation myocardial infarction secondary to a left main coronary artery thrombus after SARS-CoV-2. The patient failed anticoagulation and fibrinolysis and developed decompensated heart failure. Ultimately, the patient underwent surgical revascularization, which led to full recovery. This highlights the need for refinement in this population. We recommend that early surgical intervention be considered in patients with ST-elevation myocardial infarction secondary to left main coronary artery thrombus in the setting of SARS-CoV-2.

Similar content being viewed by others
Data availability
No data was used in the preparation of this manuscript.
References
Laubscher GJ, Lourens PJ, Venter C, Kell DB, Pretorius E. TEG®, Microclot and platelet mapping for guiding early management of severe COVID-19 coagulopathy. J Clin Med. 2021;10:5381. https://doi.org/10.3390/jcm10225381.
Pérez Espejo P, Chipayo Gonzales DA, Mogollón Jiménez MV, Portales Fernández FJ. Acute thrombosis of the right coronary artery in a patient with COVID-19. Eur Heart J Case Rep. 2020;4:1–3.
Bussmann BM, Shabbir A, Warwick A, Orr W. Acute coronary artery thrombosis presenting as asymptomatic ST-elevation myocardial infarction in a patient with COVID-19 pneumonia. BMJ Case Rep. 2021;14:e241856. https://doi.org/10.1136/bcr-2021-241856.
Akhtar Z, Leung LWM, Gallagher MM, Sharma S. Subacute left main stem thrombus in COVID-19: a case report. Eur Heart J Case Rep. 2021;5:ytab222.
Yu MD, Desai N, Sanagala T, Darki A. Paradoxical embolism causing myocardial infarction in a COVID-19 patient presenting with pulmonary embolism. Cureus. 2021;13:e13975.
Funding
No funding was received to assist with the preparation of this manuscript.
Author information
Authors and Affiliations
Contributions
RMH: writing and editing; ASE: editing; BS: editing; BM: conceptualization, writing, and editing.
Corresponding author
Ethics declarations
Competing interests
The authors have no relevant financial or non-financial interests to disclose.
Ethics approval
The Pennsylvania State University College of Medicine Institutional Review Board reviewed and granted approval for this study in January 2022.
Consent to participate
Informed consent to publish was obtained from the patient prior to the initiation of this manuscript.
Statement of human and animal rights
The procedures followed in this patient’s case were in accordance with the ethical standards of the Pennsylvania State University College of Medicine Institutional Review Board and with the Helsinki Declaration. No animals were used in this study.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Holcomb, R.M., Elnaggar, A.S., Soleimani, B. et al. Treatment of left main coronary artery thrombus during SARS-CoV-2: early surgical revascularization is key. Indian J Thorac Cardiovasc Surg 40, 716–718 (2024). https://doi.org/10.1007/s12055-024-01714-9
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12055-024-01714-9